Logo image of NBR

NABORS INDUSTRIES LTD (NBR) Stock Fundamental Analysis

NYSE:NBR - New York Stock Exchange, Inc. - BMG6359F1370 - Common Stock - Currency: USD

26.62  +0.43 (+1.64%)

After market: 26.62 0 (0%)

Fundamental Rating

2

Overall NBR gets a fundamental rating of 2 out of 10. We evaluated NBR against 63 industry peers in the Energy Equipment & Services industry. Both the profitability and financial health of NBR have multiple concerns. NBR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

NBR had negative earnings in the past year.
In the past year NBR had a positive cash flow from operations.
In the past 5 years NBR always reported negative net income.
Each year in the past 5 years NBR had a positive operating cash flow.
NBR Yearly Net Income VS EBIT VS OCF VS FCFNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

NBR's Return On Assets of -2.76% is on the low side compared to the rest of the industry. NBR is outperformed by 73.02% of its industry peers.
The Return On Equity of NBR (-40.73%) is worse than 84.13% of its industry peers.
With a Return On Invested Capital value of 3.93%, NBR is not doing good in the industry: 69.84% of the companies in the same industry are doing better.
NBR had an Average Return On Invested Capital over the past 3 years of 3.54%. This is significantly below the industry average of 8.65%.
The last Return On Invested Capital (3.93%) for NBR is above the 3 year average (3.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.76%
ROE -40.73%
ROIC 3.93%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
NBR Yearly ROA, ROE, ROICNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 7.43%, NBR is doing worse than 61.90% of the companies in the same industry.
NBR has a better Gross Margin (40.24%) than 79.37% of its industry peers.
NBR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.43%
PM (TTM) N/A
GM 40.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
NBR Yearly Profit, Operating, Gross MarginsNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NBR is destroying value.
The number of shares outstanding for NBR has been increased compared to 1 year ago.
Compared to 5 years ago, NBR has more shares outstanding
Compared to 1 year ago, NBR has an improved debt to assets ratio.
NBR Yearly Shares OutstandingNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
NBR Yearly Total Debt VS Total AssetsNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NBR has an Altman-Z score of 0.33. This is a bad value and indicates that NBR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.33, NBR is doing worse than 79.37% of the companies in the same industry.
A Debt/Equity ratio of 7.84 is on the high side and indicates that NBR has dependencies on debt financing.
NBR has a Debt to Equity ratio of 7.84. This is amonst the worse of the industry: NBR underperforms 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.84
Debt/FCF N/A
Altman-Z 0.33
ROIC/WACC0.57
WACC6.91%
NBR Yearly LT Debt VS Equity VS FCFNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.80 indicates that NBR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.80, NBR is in line with its industry, outperforming 44.44% of the companies in the same industry.
NBR has a Quick Ratio of 1.62. This is a normal value and indicates that NBR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NBR (1.62) is better than 63.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.62
NBR Yearly Current Assets VS Current LiabilitesNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

NBR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.37%.
Looking at the last year, NBR shows a decrease in Revenue. The Revenue has decreased by -0.95% in the last year.
NBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.76% yearly.
EPS 1Y (TTM)6.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.02%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%-0.15%

3.2 Future

Based on estimates for the next years, NBR will show a very strong growth in Earnings Per Share. The EPS will grow by 32.24% on average per year.
The Revenue is expected to grow by 7.14% on average over the next years.
EPS Next Y76.77%
EPS Next 2Y39.29%
EPS Next 3Y32.24%
EPS Next 5YN/A
Revenue Next Year13.25%
Revenue Next 2Y9.78%
Revenue Next 3Y7.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NBR Yearly Revenue VS EstimatesNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
NBR Yearly EPS VS EstimatesNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

NBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBR Price Earnings VS Forward Price EarningsNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NBR is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.16
NBR Per share dataNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

NBR's earnings are expected to grow with 32.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.29%
EPS Next 3Y32.24%

More info and screens

0

5. Dividend

5.1 Amount

NBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NABORS INDUSTRIES LTD

NYSE:NBR (5/27/2025, 7:00:00 PM)

After market: 26.62 0 (0%)

26.62

+0.43 (+1.64%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners88.94%
Inst Owner Change41.41%
Ins Owners6.13%
Ins Owner Change7.14%
Market Cap417.93M
Analysts52
Price Target48.81 (83.36%)
Short Float %9.99%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-73.53%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.28%
Min EPS beat(2)-287.9%
Max EPS beat(2)171.33%
EPS beat(4)1
Avg EPS beat(4)-83.09%
Min EPS beat(4)-287.9%
Max EPS beat(4)171.33%
EPS beat(8)1
Avg EPS beat(8)-861.98%
EPS beat(12)3
Avg EPS beat(12)-667.87%
EPS beat(16)3
Avg EPS beat(16)-509.57%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)2.22%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)2.22%
Revenue beat(8)2
Avg Revenue beat(8)-1.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.02%
PT rev (1m)-19.08%
PT rev (3m)-37.85%
EPS NQ rev (1m)-15.68%
EPS NQ rev (3m)-84.84%
EPS NY rev (1m)-6.24%
EPS NY rev (3m)-16.15%
Revenue NQ rev (1m)1.01%
Revenue NQ rev (3m)1.22%
Revenue NY rev (1m)1.23%
Revenue NY rev (3m)-3.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF 0.74
P/B 1.22
P/tB 1.22
EV/EBITDA 3.16
EPS(TTM)-12.93
EYN/A
EPS(NY)-1.18
Fwd EYN/A
FCF(TTM)-4.22
FCFYN/A
OCF(TTM)35.79
OCFY134.45%
SpS186.79
BVpS21.83
TBVpS21.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.76%
ROE -40.73%
ROCE 4.97%
ROIC 3.93%
ROICexc 4.34%
ROICexgc 4.34%
OM 7.43%
PM (TTM) N/A
GM 40.24%
FCFM N/A
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
ROICexc(3y)4.37%
ROICexc(5y)N/A
ROICexgc(3y)4.37%
ROICexgc(5y)N/A
ROCE(3y)4.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 7.84
Debt/FCF N/A
Debt/EBITDA 3.17
Cap/Depr 99.66%
Cap/Sales 21.42%
Interest Coverage 250
Cash Conversion 66.24%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.62
Altman-Z 0.33
F-Score4
WACC6.91%
ROIC/WACC0.57
Cap/Depr(3y)76.54%
Cap/Depr(5y)57.36%
Cap/Sales(3y)17.15%
Cap/Sales(5y)14.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.02%
EPS Next Y76.77%
EPS Next 2Y39.29%
EPS Next 3Y32.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%-0.15%
Revenue Next Year13.25%
Revenue Next 2Y9.78%
Revenue Next 3Y7.14%
Revenue Next 5YN/A
EBIT growth 1Y-16.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year277.65%
EBIT Next 3Y65.43%
EBIT Next 5YN/A
FCF growth 1Y-132.19%
FCF growth 3Y-58.66%
FCF growth 5Y-44.51%
OCF growth 1Y-8.45%
OCF growth 3Y10.68%
OCF growth 5Y-3.21%